Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Dunne

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
BMC Infectious Diseases|March 20, 2009
Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised, placebo-controlled trialRobert Tweyongyere, Patrice A Mawa, Nicholas O Emojong, et al.
The Journal of Infectious Diseases|July 9, 2014
Human Schistosoma haematobium antifecundity immunity is dependent on transmission intensity and associated with immunoglobulin G1 to worm-derived antigensShona Wilson, Frances M Jones, Govert J van Dam, et al.
The FEBS Journal|May 3, 2006
IPSE/alpha-1, a major secretory glycoprotein antigen from schistosome eggs, expresses the Lewis X motif on core-difucosylated N-glycansManfred Wuhrer, Crina I A Balog, M I Catalina, et al.
Tropical Medicine & International Health : TM & IH|December 14, 2007
Hepatosplenomegaly in Kenyan schoolchildren: exacerbation by concurrent chronic exposure to malaria and Schistosoma mansoni infectionShona Wilson, Birgitte J Vennervald, Hilda Kadzo, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 21, 2004
Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoniBirgitte J Vennervald, Mark Booth, Anthony E Butterworth, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 13, 2009
Health implications of chronic hepatosplenomegaly in Kenyan school-aged children chronically exposed to malarial infections and Schistosoma mansoniShona Wilson, Birgitte J Vennervald, Hilda Kadzo, et al.
Plos Neglected Tropical Diseases|March 31, 2010
Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoniCarla L Black, Pauline N M Mwinzi, Erick M O Muok, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Carriage of DRB1*13 is associated with increased posttreatment IgE levels against Schistosoma mansoni antigens and lower long-term reinfection levelsMark Booth, Marie A Shaw, Danielle Carpenter, et al.
The Journal of Infectious Diseases|July 10, 2004
Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 coinfectionSarah Joseph, Frances M Jones, Maureen E Laidlaw, et al.
Journal of Clinical Microbiology|February 26, 2010
Association of schistosomiasis with false-positive HIV test results in an African adolescent populationDean B Everett, Kathy J Baisely, Ruth McNerney, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
BMC Infectious Diseases|March 20, 2009
Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised, placebo-controlled trialRobert Tweyongyere, Patrice A Mawa, Nicholas O Emojong, et al.
The Journal of Infectious Diseases|July 9, 2014
Human Schistosoma haematobium antifecundity immunity is dependent on transmission intensity and associated with immunoglobulin G1 to worm-derived antigensShona Wilson, Frances M Jones, Govert J van Dam, et al.
The FEBS Journal|May 3, 2006
IPSE/alpha-1, a major secretory glycoprotein antigen from schistosome eggs, expresses the Lewis X motif on core-difucosylated N-glycansManfred Wuhrer, Crina I A Balog, M I Catalina, et al.
Tropical Medicine & International Health : TM & IH|December 14, 2007
Hepatosplenomegaly in Kenyan schoolchildren: exacerbation by concurrent chronic exposure to malaria and Schistosoma mansoni infectionShona Wilson, Birgitte J Vennervald, Hilda Kadzo, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 21, 2004
Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoniBirgitte J Vennervald, Mark Booth, Anthony E Butterworth, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 13, 2009
Health implications of chronic hepatosplenomegaly in Kenyan school-aged children chronically exposed to malarial infections and Schistosoma mansoniShona Wilson, Birgitte J Vennervald, Hilda Kadzo, et al.
Plos Neglected Tropical Diseases|March 31, 2010
Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoniCarla L Black, Pauline N M Mwinzi, Erick M O Muok, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Carriage of DRB1*13 is associated with increased posttreatment IgE levels against Schistosoma mansoni antigens and lower long-term reinfection levelsMark Booth, Marie A Shaw, Danielle Carpenter, et al.
The Journal of Infectious Diseases|July 10, 2004
Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 coinfectionSarah Joseph, Frances M Jones, Maureen E Laidlaw, et al.
Journal of Clinical Microbiology|February 26, 2010
Association of schistosomiasis with false-positive HIV test results in an African adolescent populationDean B Everett, Kathy J Baisely, Ruth McNerney, et al.
Pageof 12